Structure-based virtual screening of chemical database and identification of hit compounds by biophysical analyses (targets: epigenome modulators (HDACs, HMT, DNMT), Z-DNA binding protein, RNA pseudoknot and stem-loop, G-quadruplex, kinases, GPCR)
3D-QSAR/QSPR studies on various bioactive compounds
Identification of G-quadruplex binding proteins and their biological function
Development of GPCR agonists as antidiabetic agents
학력
(Ph.D.) 이학박사, The University of Texas at Austin, 미국
(BS/MS) 학사/석사, 서울대학교 약학대학
약력/경력
1997-2000 Massachusetts Institute of Technology, 미국, 박사후연구원
2000-2010 성균관대학교 약학대학 조교수, 부교수
2011-현재 성균관대학교 약학대학 교수
2015-2016 Duke University, 미국, 방문교수
2019-2021 INDICASAT-AIP, 파나마, 겸임 교수
학술지 논문
(2024)
Development of a tetrahydroindazolone-based HDAC6 inhibitor with in-vivo anti-arthritic activity.
BIOORGANIC & MEDICINAL CHEMISTRY.
99,
1
(2023)
Synthesis and biological evaluation of novel N-benzyltriazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors.
BIOORGANIC & MEDICINAL CHEMISTRY.
79,
1
(2022)
Rapid discovery and classification of inhibitors of coronavirus infection by pseudovirus screen and amplified luminescence proximity homogeneous assay.
ANTIVIRAL RESEARCH.
209,
1
(2022)
A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response.
ONCOGENE.
41,
23
(2022)
A novel C-terminal heat shock protein 90 inhibitor that overcomes STAT3-Wnt-beta-catenin signaling-mediated drug resistance and adverse effects.
THERANOSTICS.
12,
1
(2021)
Discovery of a simplified deguelin analog as an HSP90 C-terminal inhibitor for HER2-positive breast cancer.
BIOORGANIC MEDICINAL CHEMISTRY LETTERS.
45,
6
(2021)
Design, Synthesis, and Biological Evaluation of Imidazopyrazinone Derivatives as Antagonists of Inhibitor of Apoptosis Proteins (IAPs).
BULLETIN OF THE KOREAN CHEMICAL SOCIETY.
42,
6
(2021)
Structure-Activity Relationship Study and Biological Evaluation of 2-(Disubstituted phenyl)-indole-5-propanoic Acid Derivatives as GPR40 Full Agonists.
JOURNAL OF MEDICINAL CHEMISTRY.
64,
7
(2020)
QSAR Model for Predicting the Cannabinoid Receptor 1 Binding Affinity and Dependence Potential of Synthetic Cannabinoids.
MOLECULES.
25,
24
(2020)
A novel HSP90 inhibitor targeting the C-terminal domain attenuates trastuzumab resistance in HER2-positive breast cancer.
MOLECULAR CANCER.
19,
1
(2020)
Discovery of novel anti-breast cancer agents derived from deguelin as inhibitors of heat shock protein 90 (HSP90).
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS.
30,
17
(2020)
Synthesis, biological evaluation and molecular modelling of 2,4-disubstituted-5-(6-alkylpyridin-2-yl)-1H-imidazoles as ALK5 inhibitors.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY.
35,
1
(2020)
PBT-6, a Novel PI3KC2 gamma Inhibitor in Rheumatoid Arthritis.
BIOMOLECULES & THERAPEUTICS.
28,
2
(2020)
Absolute Configuration and Corrected NMR Assignment of 17-Hydroxycyclooctatin, a Fused 5-8-5 Tricyclic Diterpene.
JOURNAL OF NATURAL PRODUCTS.
83,
2
(2020)
Antithrombotic effect of SP-8008, a benzoic acid derivative, through the selective inhibition of shear stress-induced platelet aggregation.
BRITISH JOURNAL OF PHARMACOLOGY.
177,
4
(2019)
Lobatamunsolides A-C, Norlignans from the Roots of Pueraria lobata and their Nitric Oxide Inhibitory Activities in Macrophages.
BIOMOLECULES.
9,
12
(2019)
Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer.
BMC CANCER.
19,
1
(2019)
Structure-activity relationship study of thiazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors.
BIOORGANIC & MEDICINAL CHEMISTRY.
27,
15
(2019)
Computer-Aided Discovery of Massonianoside B as a Novel Selective DOT1L Inhibitor.
ACS CHEMICAL BIOLOGY.
14,
5
(2019)
Structure-Activity Relationship of Sulfonyl Piperazine LpxH Inhibitors Analyzed by an LpxE-Coupled Malachite Green Assay.
ACS INFECTIOUS DISEASES.
5,
4
단행본
(2013)
Biophysical approaches to translational control of gene expression, Biophysics for the Life Sciences Volume 1.
Springer.
공동
(2004)
의약화학.
도서출판 신일상사.
공동
(2001)
의약화학.
도서출판 신일상사.
공동
특허/프로그램
GPR40 효능제 활성을 갖는 신규 화합물 및 이의 용도(Novel compounds having GPR40 agonistic activity and use thereof).
10-2017-0014871.
20180306.
대한민국
Ｇ－ｑｕａｄｒｕｐｌｅｘ ＤＮＡ와 결합하는 신규 화합물, 그 제조 방법 및 이용.
10-2012-0055692.
20140827.
대한민국
Homopiperazine compounds that inhibit ribosomal frameshifting by binding to RNA pseudinot structure of SARS coronavirus.
JP2007- 329428.
20110805.
일본
사스 코로나 바이러스의 RNA유사매듭구조에 결합하여 리보솜틀이동을 억제하는 호모피페라진계 화합물.
10-2006-0132761.
20110104.
대한민국
Z-DNA 결합단백질의 활성을 제어하는 피라졸리딘계 화합물.
10-2006-0132754.
20101105.
대한민국
Homopiperazine compounds that inhibit ribosomal frameshifting by binding to RNA pseudinot structure of SARS coronavirus.
11/961,781.
20100928.
미국
수상/공훈
교육과학기술부 선정 ‘2012 기초연구 우수성과 50선’ 및 국가과학기술위원회 선발 '2012 정부연구개발 우수성과' 에 선정 (연구 제목: 선도물질 최적화 연구를 통한 항바이러스 후보물질로서 사스 바이러스의 리보솜 틀이동 조절제 개발)
학술회의논문
(2023)
In Silico Modeling of RNA Pseudoknot Structure in SARS-CoV2 to Identify the Binding Site for Frameshifting Inhibitors.
EFMC International Symposium on Chemical Biology.
스위스
(2023)
Synthesis and Biological Evaluation of 3-Aryl propionic acid GPR120 Agonists as Antidiabetic Agents.
EFMC International Symposium on Chemical Biology.
스위스
(2022)
Identification of inhibitors of -1 programmed ribosomal frameshifting in SARS coronavirus 2.
대한약학회 추계학술대회.
대한민국
(2019)
Identification of Menin-MLL Inhibitor Candidates by Optimized Virtual Screening Method.
제20회 한국유기합성학회 학술대회(추계학술대회).
대한민국
(2019)
SAR and Mechanistic Study to Develop Novel Allosteric GPR40 Full Agonists.
제20회 한국유기합성학회 학술대회(추계학술대회).
대한민국
(2019)
Structure-Activity Relationships study and biological evaluation of Indole-5-propanoic acid GPR40 agonist.
제20회 한국유기합성학회 학술대회(추계학술대회).
대한민국
(2018)
In Silico Identification of Ligands for Epigenetic Targets.
The 3rd A3 Roundtable Meeting on Chemical Probe Research Hub.
대한민국
(2018)
Machine Learning Based QSAR Modeling of Phencyclidine Derivatives to Predict in vivo Addictive Properties.
Asia Hub for e-Drug Discovery (AHeDD) 2018.
대한민국
(2018)
Virtual Screening to Identify Novel Menin-MLL Inhibitors Using Machine-Learning Consensus Scoring Method.
Asia Hub for e-Drug Discovery (AHeDD) 2018.
대한민국
(2018)
Identification and Development of Ligands for Epigenetic Targets by Computational Approaches.
Asia Hub for e-Drug Discovery (AHeDD) 2018.
대한민국
(2018)
Identification of Protoberberine Alkaloids as Novel Histone Methyltransferase G9a
Inhibitors by In Silico Screening.
XXII International Conference on Organic Synthesis (22-ICOS).
이탈리아
(2017)
Identification and development of ligands for epigenetic targets by computational approaches.
2017 Fall International Convention of The Pharmaceutical Society of Korea.
대한민국
(2017)
Development of Indole Propanoic Acid Derivatives as New Gpr40 Agonists.
AIMECS 2017 (Asia International Medicinal Chemistry Symposia).
오스트레일리아
(2017)
Molecular Docking-Based Design of Novel HDAC6 Selective Inhibitors.
AIMECS 2017 (Asia International Medicinal Chemistry Symposia).
오스트레일리아
(2017)
QSAR Analysis of Tryptamines for Predicting in vivo Addiction Potentials.
AIMECS 2017 (Asia International Medicinal Chemistry Symposia).
오스트레일리아
(2017)
Structure-based Design Of EZH2 Inhibitors As Anticancer Agents.
AIMECS 2017 (Asia International Medicinal Chemistry Symposia).
오스트레일리아
(2017)
In Silico Design of Epigenetic Enzyme Inhibitors.
2017 Spring International Convention of The Pharmaceutical Society of Korea.
대한민국
(2016)
Computer-aided Design and Optimization of Novel HDAC6-selective Inhibitors.
대한약학회 창립70주년 국제학술대회.
대한민국
(2016)
Structure-Activity Relationships Study of Indole-Based GPR40 Agonists as Antidiabetic Candidates.
대한약학회 창립70주년 국제학술대회.
대한민국
(2016)
QSAR Modeling of Synthetic Cathinones for Predicting in vivo Addiction Potential.
21st EuroQSAR.
이탈리아
